EGFR is a tyrosine kinase, which is highly expressed in ovarian cancers, and activates the PI3K-MAPK pathway leading to protein kinase-B (PKB) and Bcl-2-phosphorylation. This evidence concerns the gene EGFR and ovarian carcinoma.